tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
ValiRx PLC (GB:VAL)
LSE:VAL
UK Market
VAL
ValiRx plc
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

ValiRx plc (VAL) Stock News & Sentiment

Compare
4 Followers
ValiRx’s Cytolytix Advances Cancer Therapeutics with Key Patent and Platform Developments
Premium
Company Announcements
ValiRx’s Cytolytix Advances Cancer Therapeutics with Key Patent and Platform Developments
13d ago
ValiRx Expands Prostate Cancer Portfolio with New Subsidiary
Premium
Company Announcements
ValiRx Expands Prostate Cancer Portfolio with New Subsidiary
19d ago
ValiRx Secures Grant to Advance Cancer Research with Open University
Premium
Company Announcements
ValiRx Secures Grant to Advance Cancer Research with Open University
1M ago
ValiRx Updates Evaluation Agreement with Stingray Bio for Cancer Therapeutics
Premium
Company Announcements
ValiRx Updates Evaluation Agreement with Stingray Bio for Cancer Therapeutics
1M ago
ValiRx Enters Licensing Agreement with Dominion Biotech for PredictRx Platform
Premium
Company Announcements
ValiRx Enters Licensing Agreement with Dominion Biotech for PredictRx Platform
1M ago
ValiRx Partners with VoxCell for Advanced Cancer Model Development
Premium
Company Announcements
ValiRx Partners with VoxCell for Advanced Cancer Model Development
2M ago
ValiRx PLC Announces Successful AGM Resolution Outcomes
Premium
Company Announcements
ValiRx PLC Announces Successful AGM Resolution Outcomes
3M ago
More GB:VAL News >

VAL News on the Web

ValiRx surges 13% on Cytolytix patent progress
Proactive Investors
Bullish
ValiRx launches prostate cancer subsidiary Blue Ribbon Bio
ShareCast
Neutral
ValiRx shares climb as new prostate cancer efforts are drawn up
Proactive Investors
Neutral
ValiRx Updates Evaluation Agreement with Stingray Bio for Cancer Therapeutics
TipRanks News
Neutral
ValiRx ends evaluation project with Imperial College London
ShareCast
Neutral
ValiRx agrees deal with 3D tumour specialist
Proactive Investors
Neutral
ValiRx's University of Dundee agreement extended
Proactive Investors
Neutral
ValiRx enters evaluation and option deal with Canada's Altus
ShareCast
Neutral

News Score - Last 7 Days

Neutral
GB:VAL
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week100%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:VAL’s Media Buzz Sentiment?
Currently, no data Available
What is GB:VAL’s weekly average amount of articles?
Currently, no data Available
What is GB:VAL’s News Sentiment?
100% of articles about GB:VAL were positive this week, compared to its sector average of 56%.
    Healthcare Stocks that are Trending in the News
    IMUXImmunic
    TVTXTravere Therapeutics
    THCTenet Healthcare
    NVSTEnvista Holdings
    RAREUltragenyx Pharmaceutical
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing